Children News and Research

RSS

Study identifies a link between mortality of newborns on ECMO and red blood cell transfusion volume

Newborns in respiratory failure who require the life-sustaining support of ECMO also require transfusion of red blood cells. But a new study indicates that the higher volume of these oxygen-carrying blood cells the babies receive, the higher their mortality rate.

14 Feb 2022

Study explores factors influencing countries with high rates of COVID-19 vaccine acceptance

A new study investigated the various factors affecting the acceptance rate and trust in SARS-CoV-2 vaccines in countries with high rates of vaccination.

14 Feb 2022

Hundreds of new proteins that could play a role in cystic fibrosis discovered

Researchers at the University of Toronto have identified hundreds of new proteins that could play a role in cystic fibrosis, and which may shed light on why some patients respond better than others to current therapies.

14 Feb 2022

Why millions on Medicaid are at risk of losing coverage in the months ahead

The Biden administration and state officials are bracing for a great unwinding: millions of people losing their Medicaid benefits when the pandemic health emergency ends. Some might sign up for different insurance. Many others are bound to get lost in the transition.

14 Feb 2022

New research could deliver a breakthrough for kids suffering from severe form of genetic epilepsy

New research from the University of South Australia could deliver a breakthrough for children suffering one of the most severe forms of genetic epilepsy, reducing the frequency of their seizures and improving their quality of life.

14 Feb 2022

Nitazoxanide shows promise for COVID-19 treatment in animal model

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that Nitazoxanide (NTZ), an oral drug, broadly inhibits replication of several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in preclinical models of infection.

13 Feb 2022

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

A nationwide study from the U.S. Centers for Disease Control and Prevention is the first to show that immunity against severe COVID-19 disease begins to wane 4 months after receipt of the third dose of an mRNA vaccine (Pfizer or Moderna).

12 Feb 2022

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

A study in mice - led by researchers at Washington University School of Medicine in St. Louis - shows that a new class of compounds the scientists developed can improve multiple aspects of metabolic syndrome.

12 Feb 2022

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Cancer patients undergoing active treatment were more likely to believe misinformation related to COVID-19 than those without a history of cancer, according to a new study led by researchers at Virginia Commonwealth University.

12 Feb 2022

Mechanical clot removal may improve recovery after severe stroke in children

Serious disability was 6 times more likely to be the result three months after stroke among children whose clot-caused stroke in a large vessel (a type of ischemic stroke) was not treated with a procedure to extract the clot, according to preliminary late-breaking science presented today at the American Stroke Association's International Stroke Conference 2022.

12 Feb 2022

New government fund will provide holidays for more than 800 families facing difficult times

Families struggling financially, or facing illness, isolation or bereavement, will have an opportunity for a weekend break thanks to a new government fund.

11 Feb 2022

Exits by Black and Hispanic teachers pose a new threat to covid-era education

Lynette Henley needed one more year to receive her full pension after 40 years as a teacher, but she couldn't convince herself it was worth the risk.

11 Feb 2022

Survey demonstrates financial and mental health damage that may outlive the COVID threat

New Yorkers entering their third year of COVID have bleak views of the near-term economy and a strong conviction that vaccines should be required for those seeking to participate in their city's indoor activities (69%), to work in its service industries (66%) or schools (69%), and even to travel on airplanes (68%).

11 Feb 2022

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Alkem Laboratories Limited, an Indian multinational pharmaceutical company, has signed a license agreement with Harvard University's Office of Technology Development enabling Alkem to develop and commercialize a novel technology that may help meet the dire need for effective treatment of diabetic neuropathy, foot ulcers, peripheral arterial disease (PAD), and other injuries caused by vascular disease.

11 Feb 2022

Scientific statement highlights the uncertainty about health effects of marijuana

Despite the perception that marijuana is harmless, there is some scientific evidence challenging that belief, and there are many unanswered questions about its impact on brain health, according to a new American Heart Association scientific statement published today in the Association's journal Stroke.

10 Feb 2022

Molecular treatment works against metastatic cancer that spread to the brain

Mount Sinai researchers conducting clinical trials of a drug targeting a cancer gene found that it increased metastatic cancer patients' survival and was able to work within the brain, according to a study published in Clinical Cancer Research in February.

10 Feb 2022

Children News and Research

Study identifies a link between mortality of newborns on ECMO and red blood cell transfusion volume

Study explores factors influencing countries with high rates of COVID-19 vaccine acceptance

Hundreds of new proteins that could play a role in cystic fibrosis discovered

Why millions on Medicaid are at risk of losing coverage in the months ahead

New research could deliver a breakthrough for kids suffering from severe form of genetic epilepsy

Nitazoxanide shows promise for COVID-19 treatment in animal model

CDC study first to show waning immunity after third dose of mRNA COVID-19 vaccine

New class of compounds can improve multiple aspects of metabolic syndrome, mice study shows

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Mechanical clot removal may improve recovery after severe stroke in children

New government fund will provide holidays for more than 800 families facing difficult times

Exits by Black and Hispanic teachers pose a new threat to covid-era education

Survey demonstrates financial and mental health damage that may outlive the COVID threat

Alkem signs license agreement with Harvard to develop, commercialize new technology for treating ischemic conditions

Scientific statement highlights the uncertainty about health effects of marijuana

Molecular treatment works against metastatic cancer that spread to the brain

Study paves the way for efficient one-dose strategy to reduce scabies prevalence

Study reveals a significant gap in disadvantaged children’s financial skills

Nine new Discovery Grants awarded to fuel the development of ALS treatments

Survey shows increase in human exposure to potentially harmful pesticide

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News